Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $65.00 USD
Change Today 0.00 / 0.00%
Volume 0.0
ALSE On Other Exchanges
As of 8:10 PM 07/20/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter G. Savas

Executive Chairman, Chief Executive Officer and Member of Finance Committee, Alseres Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 30 board members in 4 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Peter G. Savas is an Associate Partner of Incyte Ventures. Mr. Savas has executive leadership including 19 years of Chief Executive Officer experience. He is an employee of MacroChem Corporation. He serves as a Managing Partner of Tughill Partners. He has been the Executive Chairman and Chief Executive Officer of Alseres Pharmaceuticals Inc. since September 8, 2004. He is employed at He was recruited in 2000 where he raised $45 million in new capital; attracted world-class ...

Read Full Background

Corporate Headquarters*

275 Grove Street
Auburndale, Massachusetts 02466

United States

Phone: 508-497-2360
Fax: --

Board Members Memberships*

Non-Executive Director
Chairman of the Board
Executive Chairman, Chief Executive Officer and Member of Finance Committee
Non-Executive Director, Chairman of Governance & Nominating Committee and Member of Audit & Compliance Committee


Syracuse University
Syracuse University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$401,625

Stock Options*

Exercisable Options1,150,000
Total Number of Options1,150,000

Total Compensation*

Total Annual Cash Compensation$401,625
Total Short Term Compensation$401,625
Total Calculated Compensation$401,625
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALSE:US $65.00 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALSERES PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at